| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection
|
Mohamedi, S.A
|
|
2001
|
49 |
2 |
p. 83-99
17 p.
|
artikel
|
| 2 |
Anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)-cycloprop-1′-yl]methyl]guanine (A-5021) in vitro and in vivo
|
Neyts, Johan
|
|
2001
|
49 |
2 |
p. 115-120
6 p.
|
artikel
|
| 3 |
Genetic risks of antiviral nucleoside analogues – a survey
|
Wutzler, Peter
|
|
2001
|
49 |
2 |
p. 55-74
20 p.
|
artikel
|
| 4 |
Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374
|
Sharmeen, Lamia
|
|
2001
|
49 |
2 |
p. 101-114
14 p.
|
artikel
|
| 5 |
The anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil
|
Neyts, Johan
|
|
2001
|
49 |
2 |
p. 121-127
7 p.
|
artikel
|
| 6 |
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
|
Andreone, Pietro
|
|
2001
|
49 |
2 |
p. 75-81
7 p.
|
artikel
|
Tijdschrift beschrijving